Real Monthly Costs: No Hidden Surprises
Compare Mounjaro And Wegovy: Monthly Cost Breakdown UK
The monthly cost to compare Mounjaro and Wegovy varies dramatically across the 16-week dose escalation period, making budgeting essential for treatment success. Wegovy begins at £79.99 for the 0.25mg starter dose (weeks 1-4), progressing to £94.99 for 0.5mg (weeks 5-8), then £99.99 for 1mg (weeks 9-12). The penultimate 1.7mg dose costs £139.99 (weeks 13-16), before reaching the maintenance 2.4mg dose at £209.99 monthly from week 17 onwards. Mounjaro follows its own escalation schedule with different pricing at each tier, though both treatments require the same disciplined approach to gradual dose increases.
Annual maintenance costs become more predictable once you reach the target dose, with Wegovy's 2.4mg maintenance translating to approximately £2,519.88 yearly at current pricing. When you compare Mounjaro and Wegovy long-term costs, consider that both treatments work most effectively as ongoing therapy rather than short-term solutions. Clinical evidence suggests that discontinuation often leads to weight regain, making the monthly cost commitment a long-term investment in health outcomes. Both prescription-only medicines are available through EverydayMeds with transparent pricing and no subscription traps.
Wegovy Pricing Structure And Bundle Advantages
EverydayMeds offers flexible purchasing options when you compare Mounjaro and Wegovy costs, with single pens and convenient bundles designed for treatment continuity. Our Intro Duo bundle (0.25mg & 0.5mg) provides your first 8 weeks for £169.99, whilst the Progress Duo (0.5mg & 1mg) covers weeks 5-12 for £189.99. The Ultimate Stability Trio delivers three months of maintenance 2.4mg supply for £649.99, eliminating the need for monthly reordering. These bundles ensure treatment stability without the anxiety of potential supply interruptions during your weight management journey.
Discount codes FIRST40 (new customers) and DOSE25 (returning customers) apply at checkout to reach these final prices, with no additional fees or hidden charges. When you compare Mounjaro and Wegovy affordability, consider that bundles provide convenience rather than just cost savings — fewer prescription reviews, Reliable Supply continuity, and reduced delivery frequency. The Take-It-Slow bundles allow extended time at lower doses if you experience side effects, though your prescriber will guide the optimal escalation schedule. This pricing transparency helps you budget accurately for either treatment option available through our GPhC-registered service (#9012878).
Clinical Evidence: Compare Mounjaro And Wegovy Effectiveness
The STEP trial programme demonstrated that Wegovy may support significant weight management when used alongside a reduced-calorie diet and increased physical activity. STEP 1 showed participants achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, whilst STEP 5 demonstrated that these results can be sustained at 2 years with continued treatment. The SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events, adding clinical value beyond weight management.
Mounjaro's clinical evidence comes from the SURMOUNT trials, though direct head-to-head comparisons between the treatments haven't been conducted with identical trial populations and endpoints. When you compare Mounjaro and Wegovy clinical data, both have demonstrated efficacy in their respective trial programmes, but individual responses vary significantly. Your prescriber can help evaluate which treatment's evidence profile aligns better with your health goals and medical history during the clinical assessment process.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone released when you eat. This mechanism may help reduce appetite by acting on brain centres that control hunger and satiety, potentially leading to smaller portion sizes and reduced food cravings. The once-weekly injection provides steady medication levels, designed to support consistent appetite regulation throughout the week. Unlike Mounjaro which targets both GIP and GLP-1 receptors (dual agonist), Wegovy focuses specifically on the GLP-1 pathway. The treatment works most effectively when combined with lifestyle modifications including a reduced-calorie diet and increased physical activity. Individual responses to the GLP-1 mechanism vary, which is why gradual dose escalation helps optimise effectiveness whilst minimising potential side effects.
EverydayMeds Ordering Process And Timeline
Accessing either treatment when you compare Mounjaro and Wegovy through EverydayMeds begins with a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your application within 3 working days (or 24 hours with express service), ensuring clinical appropriateness before approving your prescription-only medicine. Once approved, your Wegovy pens are dispatched via next-day delivery using cold-chain temperature-controlled packaging to maintain medication integrity. The FlexTouch pre-filled pens arrive with comprehensive injection instructions and dosing schedule guidance. Our clinical team remains available for ongoing support throughout your treatment journey, with straightforward reordering through your patient dashboard when you're ready to progress to the next dose or continue maintenance therapy.
Storage Requirements: Compare Mounjaro And Wegovy Practicality
Storage considerations may influence your decision when you compare Mounjaro and Wegovy for practical convenience, particularly if you travel frequently or lack consistent refrigeration access. Wegovy pens must be stored in the fridge at 2-8°C before first use, but can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration. This provides significantly more flexibility than Mounjaro's 21-day room temperature limit, making Wegovy more suitable for extended travel or variable living situations. The FlexTouch pen design is robust and travel-friendly, with a clear dose counter showing remaining doses. Once opened, each pen provides 4 weekly doses before replacement, and the pen cap must be replaced after each injection to protect the needle. This storage advantage often factors into treatment choice for patients with active lifestyles or irregular schedules.
Compare Mounjaro And Wegovy: Long-Term Budget Planning
Long-term financial planning becomes essential when you compare Mounjaro and Wegovy, as both treatments work most effectively as ongoing therapy rather than short-term interventions. Wegovy's maintenance cost of £209.99 monthly translates to approximately £2,519.88 annually, though many patients find this investment worthwhile when considering the potential health benefits and reduced comorbidity risks. The DOSE25 code for returning customers ensures continued access to discounted pricing, making long-term treatment more affordable than standard pharmacy rates. Treatment breaks or intermittent use typically require restarting the dose escalation process, potentially increasing overall costs and delaying optimal results.
When you compare Mounjaro and Wegovy financial commitments, consider that clinical evidence suggests weight regain commonly occurs after treatment discontinuation, making sustained use more cost-effective than repeated start-stop cycles. Many patients factor the monthly cost against potential savings from reduced food consumption, fewer weight-related health complications, and improved quality of life. Both treatments are available through EverydayMeds with transparent pricing and no subscription obligations, allowing you to maintain control over your treatment duration and financial commitment.
Treatment Selection: Compare Mounjaro And Wegovy With Expert Guidance
The decision to compare Mounjaro and Wegovy ultimately depends on individual medical factors, lifestyle considerations, and cost preferences that your prescriber can help evaluate. Wegovy's single GLP-1 receptor mechanism provides proven efficacy with established clinical evidence, whilst Mounjaro's dual GIP and GLP-1 approach offers a different therapeutic pathway. Both treatments require commitment to lifestyle modifications including a reduced-calorie diet and increased physical activity for optimal results. Storage requirements, injection frequency, and monthly cost structures differ between treatments, though both follow similar dose escalation principles over 16 weeks. Your clinical assessment will consider these factors alongside your medical history, current medications, and weight management goals to determine the most appropriate option. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which is right for you through our comprehensive clinical evaluation process.
Ready to start your weight management journey? Use code FIRST40 for new customers or DOSE25 for returning patients at checkout to access our best pricing on Wegovy. Our clinical team provides ongoing support throughout your treatment, with next-day delivery ensuring uninterrupted therapy. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and discover how professional weight management support can help you achieve your health goals. EverydayMeds combines clinical expertise with competitive pricing, making effective weight management accessible through our fully licensed UK pharmacy service. Trust our GPhC-registered prescribers (#9012878) to guide you towards the most suitable treatment option for your individual circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
